Frontlight ResearchEarly access
Mantle cell lymphoma trials in United States
11 of 82 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleObservational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
- Where
- Bethesda
- Age
- 18 years to 110 years
- People
- 135
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT05724121 - No phaseTaking peopleTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Where
- Chapel Hill
- Age
- 18 years to 120 years
- People
- 15,000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137643 - No phaseTaking peopleVaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
- Where
- Portland
- Age
- 18 years and over
- People
- 45
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT06784167 - No phaseNot yet taking people in United StatesAtrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy
- Where
- Duarte, San Diego, Stanford
- Age
- 18 years and over
- People
- 500
- Run by
- Tina Baykaner
See details and how to joinNCT07711327 - No phaseTaking peopleEvaluation of Human Immune Responses Vaccination in Patients With Lymphoma
- Where
- Atlanta
- Age
- 18 years and over
- People
- 200
- Run by
- Emory University
See details and how to joinNCT03501576 - No phaseTaking peopleRegistry of Older Patients With Cancer
- Where
- Boone, Chapel Hill, Greenville, Hendersonville, Morehead City, New Bern, Raleigh
- Age
- 65 years and over
- People
- 3,000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137825 - No phaseTaking peopleEvaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
- Where
- Rochester
- People
- 100
- Run by
- Mayo Clinic
See details and how to joinNCT06151730 - No phaseTaking peopleLong-term Follow-up Study of Patients Receiving CAR-T Cells
- Where
- Milwaukee
- Age
- 18 years to 80 years
- People
- 500
- Run by
- Medical College of Wisconsin
See details and how to joinNCT03375619 - No phaseTaking peopleSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Billings, Birmingham, Boise, Buffalo, Chapel Hill, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Denver, Duarte, Duluth, Fargo, Greenville, Hartford, Hattiesburg, Hempstead, Houston, Iowa City, Irvine, Jacksonville, Kansas City, La Jolla, Lansing, Little Rock, Littleton, Manhasset, Mayfield Heights, Memphis, Miami, Milwaukee, Mobile, Morgantown, Nashville, Newark, New Brunswick, New Orleans, New York, Norwalk, Omaha, Orange, Philadelphia, Portland, Providence, Salt Lake City, San Francisco, Savannah, Scarborough, Scottsdale, Seattle, Silver Spring, Stanford, Staten Island, St Louis, Tampa, Temple, Towson, Tulsa, Winston-Salem, Worcester
- People
- 50,000 worldwide
- Run by
- Massive Bio, Inc.
See details and how to joinNCT03452774 - No phaseTaking peopleA Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 300
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06788652 - No phaseTaking peopleOptimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 300
- Run by
- Adaptive Biotechnologies
See details and how to joinNCT05255354